Westchase, TX Ketamine Therapy Clinic: Direct-Acting Treatment for Depression, Anxiety, PTSD, and Chronic Pain That Standard Medications Have Failed to Resolve

There’s an important detail that gets lost in conversations about ketamine therapy: this isn’t a medication borrowed from psychiatry. It’s a medication borrowed from anesthesiology. Ketamine was developed by anesthesiologists, tested by anesthesiologists, and used by anesthesiologists for more than fifty years before anyone discovered its psychiatric applications. That origin matters — not as trivia, but as a practical reality. Even at the sub-anesthetic doses used for depression, anxiety, PTSD, and chronic pain, ketamine’s safe administration depends on the skills anesthesiologists train for: intravenous pharmacokinetics, real-time hemodynamic monitoring, precision dose management, and composed response to physiological changes.

The American Society of Anesthesiologists emphasizes that ketamine should be received in a controlled setting under the supervision of a licensed healthcare professional, with rescue equipment immediately available and continuous patient monitoring throughout treatment. That guidance reflects a simple truth: ketamine is powerfully effective, but its effectiveness depends on the hands administering it. Catalyst Health & Wellness delivers ketamine therapy to the Westchase community through three Houston-area clinics, each directed by Dr. Ho — a board-certified anesthesiologist whose primary training is in the very discipline that created this medicine. His additional pediatric board certification contributes an approach to patient interaction defined by gentleness, patience, and transparency — qualities that matter profoundly when patients arrive feeling anxious, skeptical, or both.

Ketamine’s first six decades belong to surgery. Synthesized in 1962 and FDA-approved as a general anesthetic in 1970, it became a cornerstone of operating rooms, emergency departments, pediatric care, and military field hospitals worldwide. Its safety profile, built across millions of administrations, is among the most extensively documented of any medication in modern clinical use.

The psychiatric discovery arrived uninvited. In the late 1990s, neuroscientists investigating glutamate — the brain’s dominant excitatory neurotransmitter — noticed that patients given sub-anesthetic ketamine experienced rapid, substantial depression relief. Not gradual improvement over the standard four-to-eight-week timeline. Meaningful change within hours. And specifically in the patients that every other medication had failed.

Research has since explained the mechanism completely. Conventional antidepressants boost serotonin, norepinephrine, or dopamine and rely on the brain’s slow neuroplastic adaptation. Ketamine bypasses that slow clock. By blocking NMDA receptors in the glutamate system, it initiates a molecular cascade releasing brain-derived neurotrophic factor (BDNF) — the growth protein that physically constructs new synaptic connections in brain regions governing mood, threat processing, and pain modulation. Chronic mental illness and persistent pain structurally thin these connections over time. Ketamine rebuilds them directly, often within a single session. Because this structural erosion underlies depression, anxiety, PTSD, OCD, chronic pain, and suicidal ideation alike, a single restorative mechanism can improve multiple diagnoses simultaneously.